COMMUNIQUÉS West-GlobeNewswire

Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO

21/02/2024 - 13:00

Papa will lead Emergent into a new era of focusing on protecting public health, returning to growth and paying down the company’s debt GAITHERSBURG, Md., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. ( [...]

Verge Genomics to Present at Evercore ISI 2024 Emerging Biotech Conference

21/02/2024 - 13:00

SOUTH SAN FRANCISCO, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Verge Genomics, a clinical-stage biotechnology company transforming drug discovery and development using artificial intelligence (AI) and human data, [...]

Voyager Therapeutics Announces Fourth Quarter 2023 Conference Call and Webcast

21/02/2024 - 13:00

LEXINGTON, Mass., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced it will report fourth quarter 2023 [...]

Atea Pharmaceuticals to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call on February 28, 2024

21/02/2024 - 13:00

BOSTON, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for [...]

ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlytics

21/02/2024 - 13:00

ADMAlytics Combines Generative AI and Machine Learning to Optimize Production Processes ADMA Successfully Utilized ADMAlytics’ New Capabilities for the First Time to Automate and Realize Efficiency Improvements for [...]

Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation

21/02/2024 - 12:50

DEER PARK, Ill., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare [...]

Evaxion annonce le succès des phases initiales de sa collaboration actuelle avec MSD dans le domaine des vaccins

21/02/2024 - 12:27

COPENHAGUE, Danemark, 21 févr. 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ : EVAX) (« Evaxion » ou la « Société »), une société de biotechnologie axée sur la recherche clinique spécialisée dans le développement [...]

Turnstone Biologics to Participate in Upcoming Investor Conferences

21/02/2024 - 12:00

SAN DIEGO, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotechnology company developing a differentiated approach to treat and cure [...]

Immuron Presentation Australian Biologics Festival 2024

21/02/2024 - 12:00

MELBOURNE, Australia, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to advise our Research & Development [...]

Introducing LQpay’s R2B2 - The Next Generation “Zero-Click Payment Solution,” Broadening Access for Dental Practices

21/02/2024 - 11:25

FORT LAUDERDALE, Fla., Feb. 21, 2024 (GLOBE NEWSWIRE) -- LQpay , a leader in innovative healthcare payments solutions, is proud to announce the launch of “R2B2,” the next generation of its exclusive Zero-Click Payment [...]

Inside information - BBS-Bioactive Bone Substitutes Plc: Drawdown of an advance pursuant to financing arrangement between BBS-Bioactive Bone Substitutes Plc and RiverFort to strengthen the working capital position

21/02/2024 - 09:30

BBS-Bioactive Bone Substitutes Plc, Company announcement, inside information, 21 February 2024 at 10:30 am EET Drawdown of an advance pursuant to financing arrangement between BBS-Bioactive Bone Substitutes Plc and [...]

Bavarian Nordic delivered record financial results in 2023

21/02/2024 - 08:13

Preliminary 2023 results exceed the latest guidance and represent the best-ever financial result in the Company’s history driven by extraordinary growth in travel health and a surge in smallpox/mpox vaccine sales. 2024 [...]

EssilorLuxottica and Michael Kors Announce Extended Licensing Partnership

21/02/2024 - 07:00

EssilorLuxottica and Michael Kors Announce Extended Licensing Partnership Charenton-le-Pont, France, and New York, US (February, 21 2024 – 07:00 am CET) - EssilorLuxottica and Michael Kors announced today the renewal of [...]

EssilorLuxottica et Michael Kors étendent leur accord de licence

21/02/2024 - 07:00

EssilorLuxottica et Michael Kors étendent leur accord de licence Charenton-le-Pont, France et New York, Etats-Unis (21 février 2024 – 07h00) - EssilorLuxottica et Michael Kors annoncent le renouvellement de leur accord [...]

PolTREG appoints Dan Shelly as Chief Business Development Officer

21/02/2024 - 07:00

Gdańsk, Poland – 21 February 2024 – PolTREG S.A. (Warsaw Stock Exchange: PTG), a clinical-stage biotechnology company developing cell therapies for a wide range of autoimmune diseases, announces today it has appointed [...]

Sienna Senior Living Inc. Reports Strong Fourth Quarter 2023 Financial Results and Delivers 16.5% Increase in Same Property Net Operating Income

21/02/2024 - 00:15

MARKHAM, Ontario, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced its financial results for the three months and year ended December 31, 2023. The [...]

Sanofi: Information concerning the total number of voting rights and shares - January 2024

20/02/2024 - 23:41

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]

Sanofi: Informations relatives au nombre de droits de vote et d'actions - Janvier 2024

20/02/2024 - 23:41

Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]

Turnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.

20/02/2024 - 23:00

SAN DIEGO, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotechnology company developing a differentiated approach to treat and cure [...]